GlassScriptPhysician profile
David S Kirn
NPI 1659484681
$3,145,290.33
in general payments reported to CMS, 2019-2025
11 companies · $18K in 2025
The $18K reported for 2025 was more than what 96% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $709K · 2020: $841K · 2021: $1.2M · 2022: $371K · 2023: $27K · 2024: $22K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $36K · Royalty Or License: $18K · Travel and Lodging: $5,981 · Food and Beverage: $5,352 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $36,437.60 |
| Royalty Or License | $18,160.58 |
| Travel and Lodging | $5,980.67 |
| Food and Beverage | $5,351.69 |
| Education | $316.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Technology INC | $3,120,620.28 | 2019-2025 | Amt Bridle, Nutraglide Nasal Feeding Tube, Amt Bridle Pro |
| Abbvie INC. | $12,515.00 | 2023-2025 | |
| Allergan, INC. | $8,495.48 | 2019-2023 | |
| Merz North America, INC. | $1,281.80 | 2019-2025 | Xeomin |
| Galderma Laboratories, L.P. | $942.73 | 2019-2025 | Dysport |
| Mentor Worldwide LLC | $867.78 | 2021-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander, Mentor Cpx 2 Breast Tissue Expander |
| Revance Therapeutics, INC. | $192.99 | 2024-2025 | Daxxify |
| Rti Surgical, INC | $168.41 | 2025 | |
| Motiva USA, LLC | $144.71 | 2025 | |
| Baxter Healthcare | $38.26 | 2019-2025 | Tisseel |
| Pacira Pharmaceuticals Incorporated | $22.89 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kirn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.